Find Reports

Select Report Type

Reimbursement Review

Displaying 576 - 600 of 1422

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Selexipag	Uptravi	Selexipag	cdr_SR0482_Uptravi.pdf SR0482_complete_Uptravi-Oct-28-16.pdf SR0482_Uptravi_PI_Submissions.pdf SR0482_Uptravi_CL_Report_e.pdf SR0482_Uptravi_PE_Report.pdf	Pulmonary arterial hypertension (WHO class II and III)	Reimburse with clinical criteria and/or conditions	Complete	Mar 31, 2016	Oct 28, 2016	SR0482-000
Sofosbuvir/ velpatasvir	Epclusa	Sofosbuvir/ velpatasvir	cdr_SR0486_TBC.pdf SR0486_complete_Epclusa-Oct-28-16.pdf SR0486_Epclusa_CL_Report.pdf SR0486_Epclusa_PE_Report.pdf SR0486_Epclusa_PI_Submissions.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Apr 22, 2016	Oct 26, 2016	SR0486-000
Empagliflozin	Jardiance	Empagliflozin	cdr_SR0488_Jardiance.pdf SR0488_complete_Jardiance-Oct-28-16.pdf SR0488_Jardiance_CL_Report.pdf SR0488_Jardiance_PE_Report.pdf SR0488_Jardiance_PI_Submissions.pdf	Diabetes mellitus, type 2 with high cardiovascular risk	Reimburse with clinical criteria and/or conditions	Complete	Apr 27, 2016	Oct 26, 2016	SR0488-000
Apremilast	Otezla	Apremilast	cdr_SR0478_Otezla_Resub.pdf SR0478_complete_Otezla-Oct-28-16.pdf SR0478_Otezla_PI_Submissions.pdf SR0478_Otezla_CL_Report_e.pdf SR0478_Otezla_PE_Report_e.pdf	Psoriasis, moderate to severe plaque	Reimburse with clinical criteria and/or conditions	Complete	Mar 3, 2016	Oct 26, 2016	SR0478-000
Sapropterin dihydrochloride	Kuvan	Sapropterin dihydrochloride	cdr_SR0472_Kuvan.pdf SR0472_complete_Kuvan-Oct-28-16.pdf SR0472_Kuvan_PI_Submissions.pdf SR0472_Kuvan_CL_Report_e.pdf SR0472_Kuvan_PE_Report_e.pdf	Phenylketonuria (PKU)	Reimburse with clinical criteria and/or conditions	Complete	Feb 1, 2016	Oct 26, 2016	SR0472-000
lumacaftor/ivacaftor	Orkambi	lumacaftor/ivacaftor	cdr_SR0471_Orkambi.pdf SR0471_complete_Orkambi-Oct-28-16.pdf SR0471_Orkambi_CL_Report.pdf SR0471_Orkambi_PE_Report.pdf SR0471_Orkambi_PI_Submissions.pdf	Cystic Fibrosis, F508del CFTR mutation	Do not reimburse	Complete	Jan 28, 2016	Oct 26, 2016	SR0471-000
perindopril arginine / amlodip...	Viacoram	perindopril arginine / amlodipine	cdr_SR0490_Viacoram.pdf SR0490_complete_Viacoram-Oct-28-16.pdf SR0490_Viacoram_CL_Report.pdf SR0490_Viacoram_PE_Report.pdf	Hypertension, essential	Reimburse with clinical criteria and/or conditions	Complete	May 2, 2016	Oct 26, 2016	SR0490-000
Etanercept	Brenzys	Etanercept	cdr_SE0485_TBC.pdf SE0485_complete_Brenzys-Oct-27-16.pdf se0485_brenzys_pi.pdf se0485_brenzys_seb_report.pdf	Rheumatoid arthritis, Ankylosing spondylitis	Reimburse with clinical criteria and/or conditions	Complete	Apr 20, 2016	Oct 25, 2016	SE0485-000
Infliximab	Inflectra (Subsequent Entry Biologic)	Infliximab	cdr_SE0483_Inflectra.pdf SE0483_IBD_Inflectra-Oct-28-16.pdf SE0483_Inflectra_PI_Submission_Consolidated.pdf SE0483_Inflectra_SEB_Report.pdf	Crohn’s disease and Ulcerative Colitis	Reimburse with clinical criteria and/or conditions	Complete	Apr 12, 2016	Oct 25, 2016	SE0483-000
Ixekizumab	Taltz	Ixekizumab	TS0001-PsO-Updated-Streamlined-Rec.pdf cdr_SR0481_TBC.pdf SR0481_complete_Taltz-oct-27-16.pdf SR0481_Taltz_PI_Submissions.pdf SR0481_Taltz_CL_Report_e.pdf SR0481_Taltz_PE_Report_e.pdf	Psoriasis, moderate to severe plaque	Reimburse with clinical criteria and/or conditions	Complete	Mar 23, 2016	Oct 25, 2016	SR0481-000
Empagliflozin and metformin	Synjardy	Empagliflozin and metformin	Recommendation and Reasons: Updated Submission Status Report Recommendation and Reasons: Original Patient Group Input Submissions Clinical Report Pharmacoeconomic Report	Diabetes mellitus (Type 2)	Reimburse with clinical criteria and/or conditions	Complete	Apr 29, 2016	Oct 25, 2016	SR0489-000
Lynparza for Ovarian Cancer (2...	Lynparza	Olaparib	pcodr_provfund_olaparib_lynparza_oc.pdf pcodr_olaparib_lynparza_oc_fn_rec.pdf pcodr_olaparib_lynparza_oc_fn_cgr.pdf pcodr_olaparib_lynparza_oc_fn_egr.pdf pcodr_olaparib_lynparza_oc_in_rec.pdf pcodr_olaparib_lynparza_oc_pagfdk.pdf pcodr_olaparib_lynparza_oc_fdk_azc.pdf pcodr_olaparib_lynparza_oc_ptfdk.pdf pcodr_olaparib_lynparza_oc_coi_occ.pdf pcodr_olaparib_lynparza_oc_fdk_clinician.pdf pcodr_olaparib_lynparza_oc_coi_clinician.pdf	Ovarian Cancer	Do not reimburse	Complete	Apr 1, 2016	Sep 29, 2016	PC0081-000
Zydelig for Follicular Lymphom...	Zydelig	Idelalisib	pcodr-provfund_idelalisib-zydelig-fl.pdf pcodr_idelalisib_zydelig_fl_fn_rec.pdf pcodr_idelalisib_zydelig_fl_fn_cgr.pdf pcodr_idelalisib_zydelig_fl_fn_egr.pdf pcodr_idelalisib_zydelig_fl_in_rec.pdf pcodr_idelalisib_zydelig_fl_pagfdk.pdf pcodr_idelalisib_zydelig_fl_fdk_gilead.pdf pcodr_idelalisib_zydelig_fl_ptfdk_lc.pdf pcodr_idelalisib_zydelig_fl_coi_lc.pdf	Follicular Lymphoma	Do not reimburse	Complete	Apr 12, 2016	Sep 29, 2016	PC0075-000
Lenvima for Differentiated Thy...	Lenvima	Lenvatinib	pcodr-provfund_lenvatinib-lenvima-dtc.pdf pcodr_lenvatinib_lenvima_dtc_fn_rec.pdf pcodr_lenvatinib_lenvima_dtc_fn_cgr.pdf pcodr_lenvatinib_lenvima_dtc_fn_egr.pdf pcodr_lenvatinib_lenvima_dtc_in_rec.pdf pcodr_lenvatinib_lenvima_dtc_pagfdk.pdf pcodr_lenvatinib_lenvima_dtc_fdk_eisailtd.pdf pcodr_lenvatinib_lenvima_dtc_coi_tcc.pdf pcodr_lenvatinib_lenvima_dtc_coi_clinicians.pdf	Differentiated Thyroid Cancer	Reimburse with clinical criteria and/or conditions	Complete	Apr 18, 2016	Sep 20, 2016	PC0080-000
Opdivo for Metastatic Renal Ce...	Opdivo	Nivolumab	pcodr-provfund_nivolumab-opdivo-mrcc.pdf pcodr_nivolumab_opdivo_mrcc_fn_rec.pdf pcodr_nivolumab_opdivo_mrcc_fn_cgr.pdf pcodr_nivolumab_opdivo_mrcc_fn_egr.pdf pcodr_nivolumab_opdivo_mrcc_in_rec.pdf pcodr_nivolumab_opdivo_mrcc_pagfdk.pdf pcodr_nivolumab_opdivo_mrcc_fdk_bms.pdf pcodr_nivolumab_opdivo_mrcc_ptfdk_kcc.pdf pcodr_nivolumab_opdivo_mrcc_coi_kcc.pdf	Metastatic Renal Cell Carcinoma	Reimburse with clinical criteria and/or conditions	Complete	Feb 24, 2016	Sep 1, 2016	PC0074-000
Canagliflozin and metformin hy...	Invokamet	Canagliflozin and metformin hydrochloride	cdr_SR0480_TBC.pdf SR0480_complete_Invokamet-Aug-29-16.pdf SR0480_Invokamet_Combination_Product_Subsmission_Report.pdf SR0480_Invokamet_PI_Submissions.pdf	diabetes mellitus, type 2	Reimburse with clinical criteria and/or conditions	Complete	Mar 3, 2016	Aug 25, 2016	SR0480-000
ticagrelor	Brilinta	ticagrelor	cdr_SR0474_Brilinta.pdf SR0474_complete_Brilinta-Aug-29-16.pdf SR0474_Brilinta_CL_Report.pdf SR0474_Brilinta_PE_Report.pdf SR0474_Brilinta_PI_Submissions.pdf	Prevention of atherothrombotic events with history of myocardial infarction	Reimburse with clinical criteria and/or conditions	Complete	Feb 18, 2016	Aug 25, 2016	SR0474-000
Tesamorelin	Egrifta	Tesamorelin	cdr_SR0477_Egrifta.pdf SR0477_complete_Egrifta_Aug-26-16.pdf SR0477_Egrifta_CL_Report.pdf SR0477_Egrifta_PE_Report.pdf SR0477_Egrifta_PI_Submissions.pdf	Lipodystrophy, HIV-infected patients	Do not reimburse	Complete	Mar 2, 2016	Aug 24, 2016	SR0477-000
Emtricitabine/tenofovir disopr...	Truvada	Emtricitabine/tenofovir disoproxil fumarate	cdr_SR0479_Truvada.pdf SR0479_complete_Truvada_Aug-26-16.pdf SR0479_Truvada_CL_Report.pdf SR0479_Truvada_PE_Report.pdf SR0479_Truvada_PI_Submissions.pdf	HIV-1 infection, pre-exposure prophylaxis	Reimburse with clinical criteria and/or conditions	Complete	Mar 3, 2016	Aug 24, 2016	SR0479-000
Emtricitabine /tenofovir alafe...	Descovy	Emtricitabine /tenofovir alafenamide	cdr_SR0470_TBC.pdf SR0470_complete_Descovy-Aug-26-16.pdf SR0470_Descovy_CL_Report.pdf SR0470_Descovy_PE_Report.pdf SR0470_Descovy_PI_Submissions.pdf	HIV-1 infection	Reimburse with clinical criteria and/or conditions	Complete	Jan 29, 2016	Aug 24, 2016	SR0470-000
Secukinumab	Cosentyx	Secukinumab	cdr_SR0475_Cosentyx_AS.pdf SR0475_complete_Cosentyx_AS_Aug-25-16.pdf SR0475_CosentyxAS_CL_Report.pdf SR0475_CosentyxAS_PE_Report.pdf SR0475_CosentyxAS_PI_Submissions.pdf	ankylosing spondylitis	Reimburse with clinical criteria and/or conditions	Complete	Feb 19, 2016	Aug 23, 2016	SR0475-000
Secukinumab	Cosentyx	Secukinumab	cdr_SR0476_Cosentyx_PsA.pdf SR0476_complete_Cosentyx_PsA_Aug-25-16.pdf SR0476_CosentyxPsA_CL_Report.pdf SR0476_CosentyxPsA_PE_Report.pdf SR0476_CosentyxPsA_PI_Submissions.pdf	Arthritis, psoriatic	Reimburse with clinical criteria and/or conditions	Complete	Feb 19, 2016	Aug 23, 2016	SR0476-000
Yondelis for Liposarcoma or Le...	Yondelis	Trabectedin	pcodr_provfund_trabectedin_yondelis_lipo-leio.pdf pcodr_trabectedin_yondelis_lile_scarcoma_fn_rec.pdf pcodr_trabectedin_yondelis_lile_scarcoma_fn_cgr.pdf pcodr_trabectedin_yondelis_lile_scarcoma_fn_egr.pdf pcodr_trabectedin_yondelis_lile_scarcoma_in_rec.pdf pcodr_trabectedin_yondelis_lile_scarcoma_pagfdk.pdf pcodr_trabectedin_yondelis_lile_scarcoma_fdk_janssen.pdf pcodr_trabectedin_yondelis_lile_scarcoma_coi_scfc.pdf	Metastatic Liposarcoma or Leiomyosarcoma	Do not reimburse	Complete	Dec 22, 2015	Aug 5, 2016	PC0071-000
Aflibercept	Eylea	Aflibercept	SR0460 Eylea.pdf SR0460_Eylea BRVO_complete_Jul-29_16.pdf SR0460_Eylea_BRVO_CL_Report.pdf SR0460_Eylea_BRVO_PE_Report.pdf	Macular edema, branch retinal vein occlusion	Reimburse with clinical criteria and/or conditions	Complete	Dec 14, 2015	Jul 27, 2016	SR0460-000
teduglutide	Revestive	Teduglutide	cdr_SR0459_Revestive.pdf SR0459_Revestive_complete_Jul-29_16.pdf SR0459_Revestive_CL_Report.pdf SR0459_Revestive_PE_Report.pdf SR0459_Revestive_PI_Submissions.pdf	Short bowel syndrome	Reimburse with clinical criteria and/or conditions	Complete	Nov 26, 2015	Jul 27, 2016	SR0459-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Reimbursement Status of Newer Drugs for the Treatment of Type 2 Diabetes		Feb 27, 2019	Environmental Scan	Completed	ES0337-000
Reimbursement of Newer Drugs for Type 2 Diabetes in Canada: An Environmental Scan		Feb 26, 2019	Environmental Scan	Completed	ES0337-000
Tisagenlecleucel for Acute Lymphoblastic Leukemia and Diffuse Large B-cell Lymphoma: Recommendations		Jan 15, 2019	Optimal Use	Completed	OP0538-000 / CT0001
Tisagenlecleucel (Kymriah) for Pediatric Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma	media:document:d00ebe66-c3ca-4630-a5c9-9db0789e0f05 media:document:d878e503-9902-4b9a-b462-1c08b76ea345 media:document:db2f1690-ae45-427b-926d-e7e0b29a66b6	Jan 15, 2019	Optimal Use	Completed	OP0538-000 / CT0001
Detection and Diagnosis of Sepsis in Rural and Remote Areas: An Environmental Scan		Jan 9, 2019	Environmental Scan	Completed	ES0327-000
Engaging with History Taking for Adverse Childhood Experiences in Care: A Rapid Qualitative Review	Engaging with History Taking for Adverse Childhood Experiences in Care: A Rapid…	Nov 19, 2018	Rapid Review	Completed	RC1045-000
Drugs for Rare Diseases: A Review of National and International Health Technology Assessment Agencies and Public Payers’ Decision-Making Processes		Jun 26, 2018	Environmental Scan	Completed	ES0326-000
Recommendations Framework for Drugs for Rare Diseases: A Review of National and International Health Technology Assessment Agencies and Public Payers’ Decision-Making Processes		Jun 22, 2018			ES0326-000
Drugs for the Management of Rheumatoid Arthritis		Apr 25, 2018	Health Technology Assessment	Completed	HT0010-000
Use of Real-World Evidence in Single-Drug Assessments Environmental Scan		Apr 18, 2018	Environmental Scan	Completed	ES0323-000
Gene Therapy: International Regulatory and Health Technology Assessment (HTA) Activities and Reimbursement Status		Mar 28, 2018	Environmental Scan	Completed	ES0325-000
Drugs for Type 2 Diabetes: Second-Line Therapy Review Update		Feb 7, 2018	Therapeutic Review	Completed	TR0012-000
New Drugs for Type 2 Diabetes: Second-Line Therapy — Recommendations Report		May 23, 2017			TR0012-000
Single Drug Technology Assessment Processes Across Health Technology Assessment Organizations		Dec 9, 2016	Environmental Scan	Completed	ES0293-000
Guidance Document for the Costing of Health Care Resources in the Canadian Setting: Second Edition		Mar 30, 2016			MH0002-CP0009
Drugs for Rare Diseases: Evolving Trends in Regulatory and Health Technology Assessment Perspectives	ES0300_Rare_Disease_Drugs_e.pdf	Feb 11, 2016			ES0300-000
Pruning Emtree: Does Focusing Embase Subject Headings Impact Search Strategy Precision and Sensitivity?	ATS0022_Pruning Emtree_Methods_Project_e.pdf	Apr 16, 2015
Drugs for Pulmonary Arterial Hypertension	TR0006-PAH-InBrief-e.pdf TR0006_PAH_Protocol_e.pdf TR0006_PAH_ScienceReport.pdf TR0006_PAH_Recs_Report.pdf	Mar 16, 2015			TR0006-000
Management of Relapsing-Remitting Multiple Sclerosis	TR0004_RRMS_PiB_e.pdf TR0004-000_RRMS_Protocol_e.pdf TR0004_RRMS_ScienceReport_e.pdf TR0004_RRMS_RecsReport_TR_e.pdf	Nov 29, 2012			TR0004-000
Second and Third-Line Therapy for Patients With Diabetes (Optimal Use Project)	OP0512_Diabetes_Update_PiB_e.pdf OP0512_Diabetes_RecsReport_2nd_3rd-line_e.pdf OP0512_DiabetesUpdate_Second-line_e.pdf OP0512_Diabetes Update_Third-line_e.pdf OP0512_DiabetesUpdate_Incretins-Insulin_e.pdf OU_DiabetesUpdate_Protocol_e.pdf	Dec 29, 2010			OP0512-000
Self-Monitoring of Blood Glucose	C1109_bgts_summary_report_e.pdf C1109-Project-in-Brief-final-e.pdf C1109-Gaps-and-KM-Report-final.pdf compus_BGTS_OT_Rec_e.pdf compus_Current_Practice_Report_Vol-3-Issue-5.pdf compus_CU_Report-BGTS.pdf BGTS_Consolidated_Economic_Report.pdf BGTS_SR_Report_of_Clinical_Outcomes.pdf BGTS_Summary_Protocol_FINAL.pdf	Nov 29, 2010
Portable Monitoring Devices for Diagnosis of Obstructive Sleep Apnea at Home: Review of Accuracy, Cost-Effectiveness, Guidelines, and Coverage in Canada	M0002_Executive Summary_e.pdf M0002_Portable_Monitoring_Devices_Obstructive_Sleep_Apnea_L3_e.pdf	Dec 9, 2009			M0002-000
Development and Testing of Search Filters to Identify Economic Evaluations in MEDLINE and EMBASE	H0490_Executive_Summary_e.pdf H0490_Search_Filters_for_Economic_Evaluations_mg_e.pdf	Oct 30, 2009
English-Language Restriction When Conducting Systematic Review-based Meta-analyses: Systematic Review of Published Studies	H0478_Language_Restriction_Systematic_Review_Pub_Studies_e.pdf	Feb 24, 2009
Emergency department overcrowding in Canada: What are the issues and what can be done?		May 9, 2006

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 2132

Please scroll or swipe to the right to view the full content.

Title	Description	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Timing of Ventilator Circuit Tubing Replacement		Timing of Ventilator Circuit Tubing Replacement	Sep 8, 2023	Health Technology Review	Rapid Review	Completed	RC1498-000
Telephone Triage Services	Telephone triage programs provide timely access to trained health care professionals who can assess a patient’s symptoms over the phone and provide self-care advice or referral to an appropriate level of care.	canadian_telephone_triage_programs_infographic.pdf Telephone Triage Services	Sep 7, 2023	Health Technology Review	Environmental Scan	Completed	ES0378-000
Prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC)		Implementation Advice	Aug 30, 2023	Health Technology Review	Technology Review	Completed	HC0060-000
vericiguat		Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Aug 30, 2023	Reimbursement Review		Complete	SR0758-000
atogepant		Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Aug 30, 2023	Reimbursement Review		Complete	SR0724-000
upadacitinib		Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Aug 28, 2023	Reimbursement Review		Complete	SR0759-000
Issues in Pediatric Health Care	Shortage events, the phenomena when demand exceeds supply, can affect both medical care and medical devices. The COVID-19 pandemic caused a global shortage event, the consequences of which are still being experienced beyond the peak of the pandemic (e.g., the lack of pediatric pain medication available in fall 2022).	Issues in Pediatric Health Care	Aug 25, 2023	Horizon Scan	Emerging Health Technologies	Completed	EH0116-000
Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation		Transcatheter Edge-To-Edge Valve Repair for Tricuspid Regurgitation	Aug 22, 2023	Health Technology Review	Rapid Review	Completed	RC1500-000
Artificial Intelligence in Prehospital Emergency Health Care	Health care systems in Canada, including prehospital emergency health care services, are facing staffing shortages and increased patient volumes, and are looking for creative solutions to ensure the provision of high-quality care.	Artificial Intelligence in Prehospital Emergency Health Care	Aug 18, 2023	Horizon Scan	Health Technology Update	Completed	EN0052-000
Utilization of Opioid Agonist Therapies in Canada		Utilization of Opioid Agonist Therapies in Canada	Aug 15, 2023	Health Technology Review	Technology Review	Completed	HC0064-000
cariprazine		Memorandum report to CADTH Response to the Procedural Review Panel’s Memorandum Report on the Procedural R…Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Aug 10, 2023	Reimbursement Review		Complete	SR0708-000
Non-Small Cell Lung Cancer without actionable oncogenic alterations		Final Report	Aug 10, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0029-000
Lipid Panel Screening for Adults Living With Chronic Conditions		Lipid Panel Screening for Adults Living With Chronic Conditions	Aug 10, 2023	Health Technology Review	Rapid Review	Completed	RC1497-000
Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in Infants		Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytia…	Aug 8, 2023	Health Technology Review	Technology Review	Complete	HE0044-000
Somatropin for Turner Syndrome		Somatropin for Turner Syndrome	Aug 4, 2023	Health Technology Review	Rapid Review	Completed	RC1493-000
Somatropin for Growth Hormone Deficiency		Somatropin for Growth Hormone Deficiency	Aug 4, 2023	Health Technology Review	Rapid Review	Completed	RC1492-000
At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders		At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders	Aug 4, 2023	Health Technology Review	Rapid Review	Completed	RC1495-000
ciltacabtagene autoleucel		Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Aug 2, 2023	Reimbursement Review		Complete	PG0302-000
palovarotene		Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Aug 1, 2023	Reimbursement Review		Complete	SR0761-000
Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation		Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation	Aug 1, 2023	Health Technology Review	Rapid Review	Completed	RC1496-000
Evidence Base for Virtual Primary Care		Evidence Base for Virtual Primary Care	Jul 31, 2023	Health Technology Review	Technology Review	Complete	HC0062-000
Virtual Care Rapid Scoping		Virtual Care Rapid Scoping: Main Report Virtual Care Rapid Scoping: Supporting Information Virtual Care Rapid Scoping: Summary Figures Evidence Map Virtual Care Rapid Scoping: Report Summary	Jul 31, 2023	Health Technology Review	Scoping Review	Completed	RE0041-000
ClotChip Portable Blood Clotting Sensor		ClotChip Portable Blood Clotting Sensor	Jul 31, 2023	Horizon Scan	Health Technology Update	Completed	EN0041-000
An Overview of Emerging Trends and Technologies in Ulcerative Colitis		An Overview of Emerging Trends and Technologies in Ulcerative Colitis	Jul 31, 2023	Horizon Scan	Emerging Health Technologies	Complete	EH0117-000
Individuals’ Access to Medical Imaging Results via Patient Portals		Individuals’ Access to Medical Imaging Results via Patient Portals	Jul 31, 2023	Health Technology Review	CMII Service	Completed	CM0004-000